Abstract
A novel series of benzimidazolone-containing histamine H3-receptor antagonists were prepared and their structure-activity relationship was explored. These benzimidazolone analogs demonstrate potent H3-receptor binding affinities, no P450 enzyme inhibition, and strong H3 functional activity. Compound 1o exhibits the best overall profile with H3Ki=0.95nM and rat AUC=12.9μMh.
Keywords:
Benzimidazolone; H(3)-antagonists; P450 inhibition.
Copyright © 2013 Elsevier Ltd. All rights reserved.
MeSH terms
-
Animals
-
Benzimidazoles / chemical synthesis
-
Benzimidazoles / chemistry*
-
Benzimidazoles / pharmacokinetics
-
Benzimidazoles / pharmacology*
-
Cytochrome P-450 Enzyme System / metabolism
-
Guinea Pigs
-
Histamine H3 Antagonists / chemical synthesis
-
Histamine H3 Antagonists / chemistry*
-
Histamine H3 Antagonists / pharmacokinetics
-
Histamine H3 Antagonists / pharmacology*
-
Humans
-
Rats
-
Receptors, Histamine H3 / metabolism
-
Structure-Activity Relationship
Substances
-
Benzimidazoles
-
Histamine H3 Antagonists
-
Receptors, Histamine H3
-
benzimidazolone
-
Cytochrome P-450 Enzyme System